|

EB-DUO-CAR-NK-CEA/GCC (IV) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Beijing Biotech1

Indications

  • Adenocarcinoma of Colon1
  • Colorectal Cancer Metastatic1
  • Cancer1

Other1 trial

Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.